Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Article in Expert Opinion on Therapeutic Patents (March 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Expert Opinion on Therapeutic Patents (March 2024)
Article in European Journal of Clinical Pharmacology (February 2024)
Article in Biomarker Research (February 2024)